Results 21 to 30 of about 1,118 (175)

ANÁLISE COMPARATIVA DE INTERNAÇÕES E ÓBITOS POR LINFOMA DE HODGKIN E LINFOMA NÃO HODGKIN NO ESTADO DE SÃO PAULO

Hematology, Transfusion and Cell Therapy
Introdução: O linfoma é um tipo de câncer originado nos linfócitos, encontrados nos gânglios linfáticos, que compõem o sistema linfático do corpo.
NM Dantas
doaj   +1 more source

Assessing patient perspectives on enrollment in lymphoma clinical trials

Cancer, Volume 132, Issue 8, 15 April 2026.
Abstract Background Clinical trials drive advances in lymphoma care, yet certain patient groups including socioeconomically disadvantaged, racial/ethnic groups, and women remain underrepresented. Given limited/inconsistent data regarding solutions to improve clinical trial enrollment of these groups, the authors performed a study to assess patient ...
Neha Akkad, Minxing Chen, Sophia Nguyen, Alexis Romero, Lynne Nguyen, Lorna H. McNeill, Loretta J. Nastoupil, Jason Westin, Paolo Strati, Sairah Ahmed, Liliana Vallejo, Rebeca Yzquierdo, Amy Ayers, Christopher R. Flowers, Chijioke Nze   +14 more
wiley   +1 more source

Linfoma No Hodgkin Primario de Mama: Reporte de un Caso.

ARS Medica, 2016
El linfoma no Hodgkin primario de la mama es una patología poco frecuente, constituye menos del 0,5% de todos los tumores mamarios malignos, debido a que carecen de características propias, tanto clínicas, mamográficas como ultrasonográficas.
H. Gámez Oliva, S. Batlle Zamora, Y. Blanco González, I. Córdova, S. Brito García, V. Pérez Blanco   +5 more
doaj   +1 more source

Linfoma no hodgkiniano abdominal. Presentación de un caso

Medimay, 2014
El linfoma no hodgkiniano de los niños es una neoplasia maligna originada en el sistema linfoverticular de curso generalmente fatal hasta hace poco años. Es la segunda causa de muerte por cáncer en los niños de nuestro país y es frecuente que se presente
Luz Vivian Dorvigny Linares, Bertha Poma Garcés, Ana María Alayón Perera   +2 more
doaj   +4 more sources

LEUCEMIA DE CÉLULAS PLASMOCITÁRIAS EM PACIENTE COM LINFOMA DE HODGKIN E LEUCEMIA LINFOCÍTICA CRÔNICA: RELATO DE CASO

Hematology, Transfusion and Cell Therapy, 2021
Introdução: Leucemia de células plasmocitárias (LCP) é uma neoplasia muito agressiva e rara. Mais inédito ainda é a ocorrência de LCP no paciente com diagnóstico prévio de linfoma de Hodgkin e leucemia linfocítica crônica (LLC).
LFS Dias, DCOS Lopes, AAF Ribeiro, NF Centurião, CLM Pereira, JZMD Nascimento, TS Datoguia, RL Stanzione, KB Bucci, N Hamerschlak   +9 more
doaj   +1 more source

Quality of Life and Needs of Patients Undergoing CAR‐T Cell Therapy: The Patients’ Perspective

European Journal of Cancer Care, Volume 2026, Issue 1, 2026.
Background Despite the strong emphasis in recent scientific literature on the pharmacological features of CAR‐T cells, patients’ quality of life (QoL) and needs, by contrast, have received little attention. Aim This study aims to investigate patients’ perspectives on their QoL and needs in a referral centre for CAR‐T cell treatment in Italy.
S. Alfieri, E. Criscuolo, A. Chiappella, M. Bosisio, R. Petrigliano, L. Gangeri, B. Scacciati, N. Pozzetto, M. Cani, C. Borreani, Divakar Sharma   +10 more
wiley   +1 more source

Type B non-Hodgkin lymphoma in a patient with acquired immunodeficiency virus with no detected viral load. Case report

Medisur, 2023
Acquired immunodeficiency virus infection continues to be a major public health problem not only in Ecuador but also throughout the world. Cancer is a common presentation in people living with this virus and represents the main cause of death in this ...
Edwin Marcelo Miranda Solìs, Juan Fernando Orozco Herrera   +1 more
doaj  

Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER–Medicare analysis

Cancer, Volume 131, Issue 24, 15 December 2025.
Abstract Background Clinical trials (CTs) are essential for expanding treatment options across hematologic malignancies (HM) and providing access to novel treatments. However, older adults with HM are often underrepresented in CTs, and a national‐level evaluation of factors influencing their participation is lacking.
Inna Y. Gong, Mark J. Soto, Bahar Rafinejad‐Farahani, Joseph M. Unger, Rena M. Conti, Carmen E. Guerra, Amit Oza, Meredith Rosenthal, Danielle Rodin   +8 more
wiley   +1 more source

ANÁLISE DOS DIAGNÓSTICOS DE LINFOMA DE HODGKIN E NÃO HODGKIN NO HOSPITAL DE REFERÊNCIA DA PARAÍBA: IMPACTO DA PANDEMIA DE COVID-19

Hematology, Transfusion and Cell Therapy
Objetivo: Correlacionamos os diagnósticos de linfoma de Hodgkin e linfoma não - Hodgkin em pacientes atendidos no hospital de referência oncológica da Paraíba, durante período 2019/2023, analisando as variáveis pré e pós-pandemia de COVID-19 e influência
MAOM Teixeira, NMES Alves, MBF Pimenta, LGL Leite, GGD Nóbrega, YGS Medeiros, JFM Viana, FCF Pimenta, EUG Barbosa   +8 more
doaj   +1 more source

Brexucabtagene autoleucel in‐vivo expansion and BTKi refractoriness have a negative influence on progression‐free survival in mantle cell lymphoma: Results from CART‐SIE study

British Journal of Haematology, Volume 206, Issue 2, Page 644-651, February 2025.
In this prospective, observational, real‐world, multicentre study, we evaluated 106 patients affected by mantle cell lymphoma. The patients were treated with the anti‐CD19 CAR T‐cell therapy Brexucabtagene autoleucel (brexu‐cel). Our study corroborated the association between in‐vivo CAR T‐cell expansion and progression‐free survival (PFS).
Federico Stella, Annalisa Chiappella, Martina Magni, Francesca Bonifazi, Chiara De Philippis, Maurizio Musso, Ilaria Cutini, Silva Ljevar, Anna Maria Barbui, Mirko Farina, Massimo Martino, Massimo Massaia, Giovanni Grillo, Piera Angelillo, Barbara Botto, Francesca Patriarca, Mauro Krampera, Luca Arcaini, Maria Chiara Tisi, Pierluigi Zinzani, Federica Sorà, Stefania Bramanti, Martina Pennisi, Cristiana Carniti, Paolo Corradini   +24 more
wiley   +1 more source